Microbiome Offers Rich Pickings As Takeda Becomes Enterome's Second Big Pharma Crohn's Partner

 
• By Eleanor Malone

Takeda's $50m+ deal for Enterome's EB8018 is based on a separate platform from that being used under the French company's collaboration with Johnson & Johnson.

Intestine
Crohn's disease in the intestine • Source: Shutterstock

More from Immunological

More from Therapy Areas